Klunk 2004 Pittsburgh-Compound-B (PiB) thioflavin-derivative binds A-beta plaques in vivo; FDA-approved florbetapir (Avid 2012) / flutemetamol / florbetaben; defines AD biomarker A in NIA-AA framework.
Klunk 2004 Pittsburgh-Compound-B (PiB) thioflavin-derivative binds A-beta plaques in vivo; FDA-approved florbetapir (Avid 2012) / flutemetamol / florbetaben; defines AD biomarker A in NIA-AA framework.